van der Hiel B, Blankenstein SA, Aalbersberg EA, Wondergem M, et al. 18F-FDG PET/CT During Neoadjuvant Targeted Therapy in Prior Unresectable Stage III Melanoma Patients: Can (Early) Metabolic Imaging Predict Histopathologic Response or Recurrence? Clin Nucl Med 2022 Apr 22. pii: 00003072-990000000-00102.
PMID: 35452004